Natixis Advisors LLC Has $5.13 Million Position in Addus HomeCare Co. (NASDAQ:ADUS)

Natixis Advisors LLC increased its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 4.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,561 shares of the company’s stock after purchasing an additional 1,777 shares during the period. Natixis Advisors LLC owned approximately 0.21% of Addus HomeCare worth $5,130,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in ADUS. UMB Bank n.a. raised its holdings in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares in the last quarter. Quest Partners LLC acquired a new position in Addus HomeCare in the 2nd quarter valued at $31,000. Farther Finance Advisors LLC raised its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares in the last quarter. Innealta Capital LLC acquired a new position in Addus HomeCare in the 2nd quarter valued at $44,000. Finally, EntryPoint Capital LLC acquired a new position in Addus HomeCare in the 1st quarter valued at $44,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ADUS. KeyCorp began coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Stephens boosted their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Oppenheimer boosted their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, TD Cowen boosted their price target on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Stock Up 2.9 %

Shares of ADUS stock opened at $124.32 on Friday. The firm has a market capitalization of $2.25 billion, a P/E ratio of 28.45, a P/E/G ratio of 2.10 and a beta of 1.04. Addus HomeCare Co. has a twelve month low of $85.43 and a twelve month high of $136.12. The stock’s fifty day simple moving average is $128.37 and its 200 day simple moving average is $122.86.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 EPS. As a group, equities research analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 75.23 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares in the company, valued at $429,165. This trade represents a 12.93 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,917 shares of company stock worth $3,050,082. Insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.